Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Dimasi

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Therapeutic Innovation & Regulatory Science|September 14, 2022
Assessing the Financial Value of Decentralized Clinical TrialsJoseph A DiMasi, Zachary Smith, Ingrid Oakley-Girvan, et al.
Clinical Therapeutics|June 28, 2017
Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular EntitiesJennifer M Beierlein, Laura M McNamee, Michael J Walsh, et al.
Nature Reviews. Drug Discovery|September 24, 2020
The failure to fail smartlySteven Galson, Christopher P Austin, Eeshan Khandekar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical TrialStella Stergiopoulos, Sara B Calvert, Carrie A Brown, et al.
Clinical and Translational Science|July 29, 2024
Assessing the net financial benefits of employing digital endpoints in clinical trialsJoseph A DiMasi, Abigail Dirks, Zachary Smith, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Therapeutic Innovation & Regulatory Science|September 14, 2022
Assessing the Financial Value of Decentralized Clinical TrialsJoseph A DiMasi, Zachary Smith, Ingrid Oakley-Girvan, et al.
Clinical Therapeutics|June 28, 2017
Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular EntitiesJennifer M Beierlein, Laura M McNamee, Michael J Walsh, et al.
Nature Reviews. Drug Discovery|September 24, 2020
The failure to fail smartlySteven Galson, Christopher P Austin, Eeshan Khandekar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical TrialStella Stergiopoulos, Sara B Calvert, Carrie A Brown, et al.
Clinical and Translational Science|July 29, 2024
Assessing the net financial benefits of employing digital endpoints in clinical trialsJoseph A DiMasi, Abigail Dirks, Zachary Smith, et al.
Pageof 4